tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ALLR Stock Latest News

Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO
Company AnnouncementsAllarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO
8d ago
8K
ALLR
Allarity files $50M mixed securities shelf
PremiumThe Fly
Allarity files $50M mixed securities shelf
13d ago
ALLR
Allarity reports Q3 EPS (19c) vs ($7.71) last year
PremiumThe Fly
Allarity reports Q3 EPS (19c) vs ($7.71) last year
1M ago
ALLR
ALLR Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ALLR Earnings this Week: How Will it Perform?
1M ago
ALLR
Allarity Therapeutics Advances Ovarian Cancer Study with 2X-121
PremiumCompany Announcements
Allarity Therapeutics Advances Ovarian Cancer Study with 2X-121
2M ago
ALLR
Allarity files to sell 1.56M shares of common stock for holders
PremiumThe FlyAllarity files to sell 1.56M shares of common stock for holders
3M ago
ALLR
Allarity Therapeutics Secures $2.5M Through Private Placement
Premium
Company Announcements
Allarity Therapeutics Secures $2.5M Through Private Placement
3M ago
8K
ALLR
Allarity presents new Phase 2 clinical data for Stenoparib
Premium
The Fly
Allarity presents new Phase 2 clinical data for Stenoparib
3M ago
ALLR
3 Penny Stocks to Watch Now, 8/28/25
PremiumMarket News
3 Penny Stocks to Watch Now, 8/28/25
4M ago
AIFF
ALLR
Allarity Therapeutics’ Stenoparib Receives FDA Fast Track
PremiumCompany Announcements
Allarity Therapeutics’ Stenoparib Receives FDA Fast Track
4M ago
8K
ALLR
Why Is Allarity Therapeutics Stock (ALLR) Up 95% Today?
PremiumMarket News
Why Is Allarity Therapeutics Stock (ALLR) Up 95% Today?
4M ago
ALLR
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
PremiumMarket News
Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
4M ago
T
AEO
Allarity announces FDA granted Fast Track designation to stenoparib
PremiumThe FlyAllarity announces FDA granted Fast Track designation to stenoparib
4M ago
ALLR
Allarity Therapeutics Delays 10-Q Filing
Premium
Company Announcements
Allarity Therapeutics Delays 10-Q Filing
4M ago
ALLR
Allarity initiated with a Buy at Ascendiant
Premium
The Fly
Allarity initiated with a Buy at Ascendiant
5M ago
ALLR
Allarity Therapeutics Secures New EU Commercial Agreement
PremiumCompany Announcements
Allarity Therapeutics Secures New EU Commercial Agreement
5M ago
8K
ALLR
Jeffrey S. Ervin Appointed as Allarity’s New CFO
PremiumCompany Announcements
Jeffrey S. Ervin Appointed as Allarity’s New CFO
5M ago
8K
ALLR
Allarity appoints Jeff Ervin as CFO
PremiumThe Fly
Allarity appoints Jeff Ervin as CFO
5M ago
ALLR
Allarity Therapeutics Secures Australian Patent for DRP® Platform
PremiumCompany Announcements
Allarity Therapeutics Secures Australian Patent for DRP® Platform
6M ago
8K
ALLR
Allarity Therapeutics Advances Phase 2 Stenoparib Trial
PremiumCompany AnnouncementsAllarity Therapeutics Advances Phase 2 Stenoparib Trial
6M ago
8K
ALLR
Allarity gets Australian patent acceptance notice for DRP companion diagnostic
Premium
The Fly
Allarity gets Australian patent acceptance notice for DRP companion diagnostic
6M ago
ALLR
Allarity announces second patient dosed in Phase 2 trial of stenoparib
Premium
The Fly
Allarity announces second patient dosed in Phase 2 trial of stenoparib
6M ago
ALLR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >